Publications - 'P'
Publications 2051 - 2075 de 2458
| Titre | DOI |
|---|---|
|
Prognostic Value of Microvascular Obstruction and Infarct Size, as Measured by CMR in STEMI Patients M. van Kranenburg; M. Magro; H. Thiele; S. de Waha; I. Eitel; A. Cochet; Y. Cottin; D. Atar; P. Buser; E. Wu; D. Lee; V. Bodi; G. Klug; B. Metzler; R. Delewi; P. Bernhardt; W. Rottbauer; E. Boersma; F. Zijlstra; R.J. van Geuns 2014 |
10.1016/j.jcmg.2014.05.010 |
|
Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia F. Lacombe; L. Campos; K. Allou; C. Arnoulet; A. Delabarthe; F. Dumezy; J. Feuillard; F. Genevieve; E. Guerin; J. Guy; H. Jouault; P. Lepelley; M. Maynadie; F. Solly; O.Wagner Ballon; C. Preudhomme; A. Baruchel; H. Dombret; N. Ifrah; M.C. Bene; GEIL 2018 |
10.1002/hon.2488 |
|
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies J. Trotman; S. Luminari; S. Boussetta; A. Versari; J. Dupuis; C. Tychyj; L. Marcheselli; A. Berriolo-Riedinger; A. Franceschetto; A. Julian; F. Ricard; L. Guerra; C. Haioun; I. Biasoli; H. Tilly; M. Federico; G. Salles; M. Meignan 2014 |
10.1016/S2352-3026(14)70008-0 |
|
Prognostic value of PET-CT after frontline therapy in follicular lymphoma: A pooled analysis of central review in three multicenter studies. J. Trotman; S. Luminari; S. Boussetta; A. Versari; J. Dupuis; C. Tychyj-Pinel; L. Marcheselli; A. Berriolo-Riedinger; A. Franceschetto; A. Julian; F. Ricard; L. Guerra; C. Haioun; I. Biasoli; H. Tilly; M. Federico; G.A. Salles; M. Meignan; F.O.L.L.C.O.L.L.Collaborat A 2014 |
10.1200/jco.2014.32.15_suppl.8502 |
|
Prognostic value of PET-CT after frontline therapy in follicular lymphoma: applying the 5PS in three multicenter studies J. Trotman; S. Luminari; S. Boussetta; A. Versari; J. Dupuis; C. Tychyj-Pinel; L. Marcheselli; A. Berriolo-Riedinger; A. Franceschetto; A. Julian; F. Ricard; L. Guerra; C. Haioun; I. Biasoli; H. Tilly; M. Federico; G. Salles; M. Meignan 2015 |
|
|
Prognostic value of prehospital quick sequential organ failure assessment score among patients with suspected infection P.Vaittinada Ayar; M. Delay; A. Avondo; F.X. Duchateau; P. Nadiras; F. Lapostolle; T. Chouihed; Y. Freund 2019 |
10.1097/MEJ.0000000000000570 |
|
Prognostic value of primary tumor location in stage III colon cancer is associated with RAS and BRAF mutational status. T. Julien; K.Hampig Raphael; E.Jean Francois; L.Malicot Karine; B. Ralyath; T. Josep; M. Enrico; F. Gunnar; V.Laethem Je Luc; M. Claire; B. Olivier; A. Thomas; M. Pierre; T. Josef; B. John; V.Cutsem Eric; P. Geraldine; L. Come; S. Ramon; L.Puig Pierre 2017 |
|
|
Prognostic Value of Skin Manifestations of Infective Endocarditis A. Servy; L. Valeyrie-Allanore; F. Alla; C. Lechiche; P. Nazeyrollas; C. Chidiac; B. Hoen; O. Chosidow; X. Duval; E.Infect Stu Grp 2014 |
10.1001/jamadermatol.2013.8727 |
|
Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder I. Ben Bahria-Sediki; M. Chebil; C. Sampaio; V. Martel-Frachet; M. Cherif; R. Zermani; S. Rammeh; A.Ben Ammar Gaaied; A. Bettaieb 2018 |
10.1159/000488770 |
|
Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome C. Chenevier-Gobeaux; H. Lemarechal; B. Doumenc; N. Peschanski; Y.E. Claessens; D. Borderie; P. Ray 2021 |
10.1016/j.clinbiochem.2021.02.009 |
|
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma P. McLellan; J. Henriques; F. Ksontini; S. Doat; P. Hammel; J. Desrame; I. Trouilloud; C. Louvet; D. Pietrasz; D. Vernerey; J.B. Bachet 2021 |
10.1016/j.clinre.2020.08.016 |
|
Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation E. Bailly; D. Anglicheau; G. Blancho; P. Gatault; V. Vuiblet; V. Chatelet; E. Morelon; P. Malvezzi; A. Parissiadis; J. Tourret; G. Guidicelli; J. Sayegh; C. Mousson; P. Grimbert; I. Top; M. Le Quintrec; R. Purgus; P.Francois Westeel; B. Proust; V. Chabot; Y. Lebranchu; F. Dehaut; M. Buchler 2018 |
10.1097/TP.0000000000002002 |
|
Prognostic value of the PrP(C)-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype A. Ghazi; D. Le Corre; C. Pilati; J. Taieb; T. Aparicio; A. Didelot; S. Dedhar; C. Mulot; K. Le Malicot; F. Djouadi; A. de Reynies; J.M. Launay; P. Laurent-Puig; S. Mouillet-Richard 2021 |
10.1080/2162402X.2021.1940674 |
|
Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1 L. Galland; A.Laure Le Page; J. Lecuelle; F. Bibeau; Y. Oulkhouir; V. Derangere; C. Truntzer; F. Ghiringhelli 2021 |
10.1080/2162402X.2021.1957603 |
|
Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer C. Truntzer; N. Isambert; L. Arnould; S. Ladoire; F. Ghiringhelli 2019 |
10.1016/j.ejca.2019.07.020 |
|
Prognostic value of tumor deposits for disease free survival in patients with stage Ill colon cancer: A post hoc analysis of IDEA France phase Ill trial (PRODIGE-GERCOR). J.Francois Delattre; R. Cohen; J. Henriques; A. Falcoz; J.F. Emile; S. Fratte; B. Chibaudel; J. Dauba; O.Jean Marie Dupuis; Y. Becouarn; F. Bibeau; J. Taieb; T. Andre; D. Vernerey; M. Svrcek 2019 |
10.1200/JCO.2019.37.15_suppl.3519 |
|
Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR) J.F. Delattre; R. Cohen; J. Henriques; A. Falcoz; J.F. Emile; S. Fratte; B. Chibaudel; J. Dauba; O. Dupuis; Y. Becouarn; F. Bibeau; J. Taieb; C. Louvet; D. Vernerey; T. Andre; M. Svrcek 2020 |
10.1200/JCO.19.01960 |
|
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients P. Cacoub; P. Nahon; R. Layese; L. Blaise; A.Claire Desbois; V. Bourcier; C. Cagnot; P. Marcellin; D. Guyader; S. Pol; D. Larrey; V. de Ledinghen; D. Ouzan; F. Zoulim; D. Roulot; A. Tran; J.P. Bronowicki; J.P. Zarski; G. Riachi; P. Cales; J.M. Peron; L. Alric; M. Bourliere; P. Mathurin; J.F. Blanc; A. Abergel; L. Serfaty; A. Mallat; J.D. Grange; P. Attali; Y. Bacq; C. Wartelle; T. Dao; D. Thabut; C. Pilette; C. Silvain; C. Christidis; D. Capron; G. Thiefin; D. Zucman; V. Di Martino; C.Isnard Bagnis; M. Ziol; A. Sutton; E. Letouze; F. Roudot-Thoraval; E. Audureau; A.N.R.S.C.O.12 CirVi Grp 2018 |
10.1016/j.ahj.2017.10.024 |
|
Prognostics methods and degradation indexes of proton exchange membrane fuel cells: A review H. Liu; J. Chen; D. Hissel; J. Lu; M. Hou; Z. Shao 2020 |
10.1016/j.rser.2020.109721 |
|
Prognostics of Health Status of Multi-component Systems With Degradation Interactions W. Hafsa; B. Chebel-Morello; C. Varnier; K. Medjaher; N. Zerhouni 2015 |
|
|
Prognostics of PEM fuel cell in a particle filtering framework M. Jouin; R. Gouriveau; D. Hissel; M.C. Pera; N. Zerhouni 2014 |
10.1016/j.ijhydene.2013.10.054 |
|
Prognostics of PEM fuel cells under a combined heat and power profile M. Jouin; R. Gouriveau; D. Hissel; M.Cecile Pera; N. Zerhouni 2015 |
10.1016/j.ifacol.2015.06.053 |
|
Prognostics of Proton Exchange Membrane Fuel Cells stack using an ensemble of constraints based connectionist networks K. Javed; R. Gouriveau; N. Zerhouni; D. Hissel 2016 |
10.1016/j.jpowsour.2016.05.092 |
|
Prognostics-based Energy Management in Fuel Cell Hybrid Electric Vehicle Considering RUL Uncertainty M. Yue; S. Jemei; N. Zerhouni 2020 |
10.1109/VPPC49601.2020.9330958 |
|
Program Development and Implementation of an Evidence Based Guideline for the Management of the Extremely Premature Infant in the First 72 Hours of Life M. Tinling 2019 |
10.1097/ANC.0000000000000626 |